Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "AIM"

1413 News Found

No link between the use of ranitidine and cancer risk, claims Nature
News | February 24, 2023

No link between the use of ranitidine and cancer risk, claims Nature

N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.


Claim against Dr. Reddy’s Laboratories dismissed over Revlimid in US
News | December 30, 2022

Claim against Dr. Reddy’s Laboratories dismissed over Revlimid in US

All claims against the company in the litigation have now been dismissed.


China aims to lead next bio revolution in advanced biologics, says GlobalData
News | December 15, 2022

China aims to lead next bio revolution in advanced biologics, says GlobalData

China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production


Charsire's new drug aims to capture dementia treatment market
Biotech | September 22, 2022

Charsire's new drug aims to capture dementia treatment market

Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease


Olympus Corp aims to strengthen MedTech industry with startups, says GlobalData
Medical Device | September 20, 2022

Olympus Corp aims to strengthen MedTech industry with startups, says GlobalData

Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.


Import of Medical Devices Up by Record 41% in FY22: AiMeD
News | July 24, 2022

Import of Medical Devices Up by Record 41% in FY22: AiMeD

India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21


Novavax aims COVID vaccine on Omicron in Q4
Drug Approval | July 05, 2022

Novavax aims COVID vaccine on Omicron in Q4

The vaccine is under FDA review


My aim is to help the pharmaceutical industry develop a winning strategy: Dr Rupali Paranjape
interviews | May 23, 2022

My aim is to help the pharmaceutical industry develop a winning strategy: Dr Rupali Paranjape

Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com


Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India
News | April 19, 2022

Navidea Biopharmaceuticals gets regulatory approval of Lymphoaim in India

Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025